Return to Listing

3 result(s) for

PI Name Protocol # Title
Stephen Spurgeon IRB00011766 A Phase Ib Feasibility Study of Personalized Kinase Inhibitor Therapy Combined with Induction in Acute Leukemias who Exhibit in vitro Kinase Inhibitor sensitivity
Raymond Bergan STUDY00015588 Serial Measurements of Molecular and Architectural Responses to Therapy
Jessica Leonard STUDY00018659 A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080